Please login to the form below

Not currently logged in
Email:
Password:

Shield Therapeutics’ CFO steps down

Richard Jones to leave the group in early 2017

Richard Jones is to step down from his position as chief financial officer at Shield Therapeutics early next year.

Jones joined the secondary care pharmaceutical specialist in 2010 as a non-executive director before taking on his current role a year later.

He brought nearly 30 years of financial management experience to the firm, with 16 years specialising in the healthcare sector.

Previously, Jones has served as a healthcare consultant for Grant Thornton's healthcare advisory practice, as a strategic advisory board member for Bionow and in a number of senior corporate finance roles specialising in healthcare.

Carl Sterritt, chief executive officer of Shield Therapeutics, said: “Richard has helped build the Group from its inception as a small private company through to being listed on AIM.

“I would like to thank him for his significant contribution to Shield and wish him the best in his future endeavours as we continue to grow rapidly into a commercial-stage specialty pharmaceutical business with international operations."


23rd November 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics